2-(2-Bromoethyl)-1,3-dioxolane
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
18742-02-4BrCCC1OCCO1GGZQLTVZPOGLCC-UHFFFAOYSA-N18742-02-4DTXSID40172058Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (76.4%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 55 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Status: Active Update: 14-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/16521
1,3-Dioxolane, 2-(2-bromoethyl)-: Does not have an individual approval but may be used under an appropriate group standard
Verwenden2-(2-Bromoethyl)-1,3-dioxolane is used as a pharmaceutical intermediate, dioxolanes, acetals, ketals, building blocks, chemical synthesis, organic building blocks and oxygen compounds. 1,1-(Ethylenedioxy)-3-bromopropane is used in the synthesis of EGFR inhibitors. Also used in the synthesis of orally active agents of cancer and cell proliferation with quinoline substructures. It is also used as flavouring agent.
Wird geladen…